The Taubman Institute will co-sponsor a new DNA sequencing project that aims to expand knowledge of the human genome and its role in disease. “Short Tandem Repeats in Precision Health and Human Disease” will be jointly supported by the institute and the Michigan Medicine Precision Health research initiative. The project is one of seven funded…
Their genius. Your generosity. The Taubman Institute extends its heartfelt appreciation to all of the donors who generously contributed to our Emerging Scholars on December 3, Giving Blueday. The laboratories of five researchers will receive your gifts in early January, helping them to further investigations into depression, autoimmune disorders, cancer, dementia and more. Thank you…
Improving outcomes for patients with aggressive brain tumors is the focus of the latest U-M faculty member to be named a Taubman Emerging Scholar. Daniel R. Wahl, MD, PhD, is an assistant professor in the department of Radiation Oncology. Dr. Wahl and his research team believe that targeting metabolic abnormalities may be the key to…
A physician-researcher studying life-threatening infections is the latest U-M faculty member to be named a Taubman Emerging Scholar. Scott Van Epps, MD, PhD, is an assistant professor in Emergency Medicine, Biomedical Engineering, and Macromolecular Science and Engineering. He also serves as an investigator for the Biointerfaces Institute and an associate director at the Michigan Center…
An endocrinologist whose paradigm-shifting work addresses the genetic causes of obesity and its adverse effect on metabolic health is the 2019 recipient of the Taubman Prize for Excellence in Medical Science, the University of Michigan’s Taubman Institute announced. Professor Sir Stephen O’Rahilly, M.D., of the University of Cambridge will receive the honor and the $100,000…
Taubman Emerging Scholar Michelle Kahlenberg, MD, PhD, has been named a recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE). by the White House. The PECASE is the highest honor bestowed by the United States Government to outstanding scientists and engineers who are beginning their independent research careers and who show exceptional…
The primary treatment for advanced or aggressive prostate cancer is to chemically or surgically short-circuit the body’s production of male hormones — called androgens — which drive the growth of the cancer cells. After a few years, however, the cancer invariably becomes resistant to this treatment, at which point it resumes its deadly progression. Now,…
Three young physician-scientists at U-M are kicking off 2019 with a welcome boost in funding for their research projects, through the Taubman Institute’s innovative grants program for medical school faculty. Generous donors have provided three new Taubman Emerging Scholar grants, which will accelerate the research of early-career physician-investigators at the University of Michigan. The program,…
Dates for the fall 2019 Taubman Tech Talks have been set; please mark your calendars for these informative lectures and discussions. All talks will take place from 5-6pm at the Danto Auditorium in the Frankel CVC, with networking and refreshments to follow. Topics and speakers include: September 19 – Thursday, Olivia Walch, PhD – Math…
Organ transplants are lifesaving medical miracles for more than 30,000 people per year in the United States – but they come with potentially serious side effects. Drugs that suppress the immune system keep the body from rejecting the donated organ, but they also lower the patient’s ability to fight off infections. Immune suppression can increase…